Reported about 1 month ago
After a challenging period marked by disappointing IPO performances, the biotech industry is poised for a potential turnaround with four companies planning to debut soon. Industry experts believe that the initial success of these upcoming offerings could revitalize investor interest in biotech stocks, which have seen a significant decline since a boom in 2020 and 2021. As the Nasdaq Biotech Index shows signs of recovery, the market is watching closely to see if these new entrants can instill confidence and reignite activity in the sector.
Source: YAHOO